FA
BMY icon

Friess Associates’s Bristol-Myers Squibb BMY Stock Holding History

Friess Associates’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-240,000
Closed -$13.4M – 104
2020
Q1 		$13.4M Buy
+240,000
New +$14.7M 1.33% 36
2018
Q2 		– Sell
-245,200
Closed -$15.5M – 110
2018
Q1 		$15.5M Buy
+245,200
New +$15.8M 1.27% 35
2017
Q2 		– Sell
-52,000
Closed -$2.83M – 108
2017
Q1 		$2.83M Buy
+52,000
New +$2.85M 0.27% 80

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Friess Associates's BMY Position: Q2 2020 in Review

Friess Associates sold out of Bristol-Myers Squibb (BMY) in Q2 2020, closing a stake of 240,000 shares — an estimated $13.4M sold.

Friess Associates first reported a position in BMY in Q1 2017 and held it in 3 quarters. The position peaked at $15.5M in Q1 2018. 2,189 funds tracked by Wall St. Rank hold BMY as of Q2 2020.

  • Friess Associates reported no remaining Bristol-Myers Squibb position as of Q2 2020 after selling out during the quarter.
  • Friess Associates sold 240,000 Bristol-Myers Squibb shares in Q2 2020, an estimated $13.4M.
  • Friess Associates first reported a position in Bristol-Myers Squibb in Q1 2017 and held it in 3 quarters.
  • Friess Associates's Bristol-Myers Squibb position peaked at $15.5M in Q1 2018.
  • 2,189 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2020.

Based on Friess Associates's 13F filing for Q2 2020, filed 14 Aug 2020.